Highlights of recent faculty research.

Race and satisfaction with pain management among patients with HIV receiving long-term opioid therapy

Ganguly AP, Lira MC, Lodi S, Forman LS, Colasanti JA, Williams EC, Liebschutz JM, Del Rio C, Samet JH, Tsui JI. Drug Alcohol Depend. 2021 Mar 18:108662. doi: 10.1016/j.drugalcdep.2021.108662. Online ahead of print. PMID: 33775447.

Pilot study of tolerability and safety of opioid receptor antagonists as novel therapies for chronic pain among persons living with HIV with past year heavy drinking: A randomized controlled trial

Bendiks S, Cheng DM, Blokhina E, Vetrova M, Verbitskaya E, Gnatienko N, Bryant K, Krupitsky E, Samet JH, Tsui JI. AIDS Care. 2021 Mar 7:1-10. doi: 10.1080/09540121.2021.1896663. Online ahead of print. PMID: 33682527. 

Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy

Kimmel SD, Walley AY, Lodi S, Forman LS, Liebschutz JM, Lira MC, Kim TW, Del Rio C, Samet JH, Tsui JI. AIDS. 2021 Mar 15;35(4):697-700. doi: 10.1097/QAD.0000000000002803. PMID: 33587441.

Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs

Elisabeth Poorman, Sara N. Glick, Jonathan K.D. Hiser, Elenore Bhatraju, Judith I. Tsui. Journal of Substance Abuse Treatment. Volume 129, October 2021, 108375. 

The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia

Corcorran MA, Ludwig-Baron N, Cheng DM, Lioznov D, Gnatienko N, Patts G, So-Armah K, Blokhina E, Bendiks S, Krupitsky E, Samet JH, Tsui JI. AIDS Behav. 2021 Mar 17. doi: 10.1007/s10461-021-03214-y. Online ahead of print. PMID: 33730255.

Hazardous alcohol use is associated with greater pain interference and prescription opioid misuse among persons living with HIV and chronic pain

Ngo B, Liebschutz JM, Cheng DM, Colasanti JA, Merlin JS, Armstrong WS, Forman LS, Lira MC, Samet JH, Del Rio C, Tsui JI. BMC Public Health. 2021 Mar 22;21(1):564. doi: 10.1186/s12889-021-10566-6. PMID: 33752634.

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: A randomised clinical trial

Collins SE, Duncan MH, Saxon AJ, Taylor EM, Mayberry N, Merrill JO, Hoffmann GE, Clifasefi SL, Ries RK. Lancet Psychiatry. 2021 Apr;8(4):287-300. doi: 10.1016/S2215-0366(20)30489-2. Epub 2021 Mar 10. PMID: 33713622.

Development and Pilot Testing of a Patient-Centered Web-Based Reproductive Decision Support Tool for Primary Care

Callegari LS, Nelson KM, Arterburn DE, Dehlendorf C, Magnusson SL, Benson SK, Schwarz EB, Borrero S. J Gen Intern Med. 2021 Feb 4. doi: 10.1007/s11606-020-06506-6. Online ahead of print. PMID: 33538956.

Post-traumatic stress disorder and risky opioid use among persons living with HIV and chronic pain

Bhatraju E, Liebschutz JM, Lodi S, Forman LS, Lira MC, Kim TW, Colasanti J, Del Rio C, Samet JH, Tsui JI. AIDS Care. 2021 Feb 4:1-8. doi: 10.1080/09540121.2021.1876838. Online ahead of print. PMID: 33535800.

Association of Combat Experiences with Suicide Attempts Among Active-Duty US Service Members

LeardMann CA, Matsuno RK, Boyko EJ, Powell TM, Reger MA, Hoge CW; Millennium Cohort Study. JAMA Netw Open. 2021 Feb 1;4(2):e2036065. doi: 10.1001/jamanetworkopen.2020.36065. PMID: 33528551.